Axsome's Auvelity: A New Treatment For Agitation In Alzheimer's Disease
Axsome Therapeutics Inc AXSM
$227.72
▼ -1.96%
($-4.55)
Open
$229.71
Prev Close
$232.27
Day Range
$225.71 – $230.50
52W Range
$96.09 – $235.92
Market Cap
$11.72B
Beta
0.58
EPS (TTM)
$-3.74
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-11-19 |
| Shares Out. | 51,150,000 |
| Website | axsome.com/ ↗ |
| Phone | 12123323241 |
Axsome Therapeutics Inc is a publicly traded company under the ticker symbol AXSM on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
27 analysts (2026-05-01)
📰 Latest News for AXSM
Axsome Therapeutics, Inc. (AXSM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Axsome Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Axsome Therapeutics Recognizes Mental Health Month
Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $242
RBC Capital Maintains Outperform on Axsome Therapeutics, Raises Price Target to $302
Wells Fargo Maintains Overweight on Axsome Therapeutics, Raises Price Target to $255